Encompass Health reports results for fourth quarter 2020 and issues full-year 2021 guidance and longer term growth targets
Go back to Encompass Health reports results for fourth quarter 2020 and issues full-year 2021 guidance and longer term growth targets| 11% CELGENE CORP. ELKS DUE APRIL 06, 2009 (NYSE: EHC) | Delayed: 82.80 +0.34 (0.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $82.46 | 52 Week High | $11.60 | |||
| Open | $82.35 | 52 Week Low | $4.00 | |||
| Day High | $83.62 | P/E | N/A | |||
| Day Low | $82.23 | EPS | $0.00 | |||
| Volume | 1,216,634 | |||||
